Not applicableStudy completedNCT00274794What this trial is testingVP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHLWho this might be right forLymphoma The Cleveland Clinic 55
Early research (Phase 1)Study completedNCT00003970What this trial is testingGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00016094What this trial is testingS0108 Bevacizumab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forAnaplastic Large Cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+1 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)UnknownNCT00042913What this trial is testingEpratuzumab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01290120What this trial is testingChemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin LymphomaWho this might be right forBurkitt LymphomaB-ALL Northern Italy Leukemia Group 182
Early research (Phase 1)Active Not RecruitingNCT02153580What this trial is testingCellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic LeukemiaWho this might be right forB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin LymphomaB-Cell Prolymphocytic LeukemiaHigh Grade B-Cell Lymphoma, Not Otherwise Specified+10 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00002725What this trial is testingBryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Study completedNCT02165397What this trial is testingIbrutinib With Rituximab in Adults With Waldenström's MacroglobulinemiaWho this might be right forWaldenström's Macroglobulinemia Pharmacyclics LLC. 181
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Early research (Phase 1)Study completedNCT00068315What this trial is testingBortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueHematopoietic/Lymphoid CancerNodal Marginal Zone B-cell Lymphoma+9 more National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT01254578What this trial is testingLenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Study completedNCT00068718What this trial is testingDonor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell TransplantWho this might be right forBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+3 more Fred Hutchinson Cancer Center 35
Early research (Phase 1)Ended earlyNCT00004239What this trial is testing506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Alliance for Clinical Trials in Oncology 10
Early research (Phase 1)Looking for participantsNCT07691606What this trial is testingARC-02 in B-cell NHLWho this might be right forB-cell Non Hodgkin Lymphoma Taiho Oncology, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00002908What this trial is testingBryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00089076What this trial is testingMDX-010 in Treating Patients With Recurrent or Refractory LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT03019666What this trial is testingPh I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHLWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaDiffuse Large B Cell Lymphoma+5 more Masonic Cancer Center, University of Minnesota 39